News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MATTINGLY MARTIN A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 4,500 options to buy
@ $2.07, valued at
$9.3k
|
|
| 05/14/2020 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.|
Txns:
| Granted 22,000 options to buy
@ $0.43, valued at
$9.5k
|
|
| 06/17/2019 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.635, valued at
$9.5k
|
|
| 05/15/2019 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.|
Txns:
| Granted 7,000 options to buy
@ $4.02, valued at
$28.1k
|
|
| 09/21/2018 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.|
Txns:
| Granted 12,000 options to buy
@ $2.56, valued at
$30.7k
|
|
| 06/13/2018 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.7, valued at
$40.5k
|
|
| 09/12/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2017 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.15, valued at
$32.3k
|
|
| 06/02/2016 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 05/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2016 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.|
Txns:
| Exercised 2,500 restricted stock units
@ $0 |
|
| 05/28/2013 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.|
Txns:
| Exercised 2,000 shares
@ $10.64, valued at
$21.3k
Exercised 2,000 restricted stock units
@ $0
Granted 5,000 options to buy
@ $10.73, valued at
$53.7k
Granted 2,500 restricted stock units
@ $0 |
|
| 06/04/2012 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.|
Txns:
| Bought 1,000 shares
@ $12.46, valued at
$12.5k
Granted 4,000 options to buy
@ $12.56, valued at
$50.2k
Granted 2,000 restricted stock units
@ $0 |
|
| 09/24/2010 |
4
| MATTINGLY MARTIN A (CEO) has filed a Form 4 on TRIMERIS INC|
Txns:
| Granted 89,088 options to buy
@ $2.27, valued at
$202.2k
|
|
| 06/09/2010 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.|
Txns:
| Granted 5,500 options to buy
@ $14.2, valued at
$78.1k
|
|
| 06/09/2010 |
3
| MATTINGLY MARTIN A (Director) has filed a Form 3 on ONCOGENEX PHARMACEUTICALS, INC. |
| 07/22/2009 |
4
| MATTINGLY MARTIN A (CEO) has filed a Form 4 on TRIMERIS INC |
| 01/28/2009 |
4
| MATTINGLY MARTIN A (CEO) has filed a Form 4 on TRIMERIS INC |
|
|